Immunotherapies are paradigm-shifting treatment approaches that have forever changed oncology research and drug development. With increasingly complex and specific immuno-oncology treatment modalities ...
Simply put: “We help people work with the cells,” she says. If any assay providers are interested in using high quality and reliable iPSCs to accelerate their drug discovery efforts ...
13d
News Medical on MSNMicrophysiological systems in drug discoveryNewsMedical speaks with CN Bio about the translatability between in vitro organ-on-a-chip (OOC) models, microphysiological ...
This high-throughput vision-based classification and isolation of cells has broad potential applications, ranging from cell therapy and regenerative medicine to drug discovery and diagnostics.
These cells are increasingly recognized as key tools in biomedical research, particularly in drug discovery and regenerative ... regeneration and test cell-based therapies. While use cases for ...
Momentum Biotechnologies has acquired OmicScouts GmbH, a Munich-based CRO specialized in the field of mass spectrometry-based ...
The global Stem Cell Assays Market is experiencing unprecedented growth, driven by advancements in regenerative medicine, ...
RASTRUM Allegro makes it easier than ever to create high-throughput 3D cell culture assays that offer both ... Transforming Drug Discovery Workflows RASTRUM Allegro is already transforming ...
Hosted on MSN11mon
Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discoverySemarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell ... drug discovery. Designed specifically to augment microplate ...
Hosted on MSN2mon
AI aids in discovery of potential glaucoma drug candidates"AI provides reliable tools and methods for drug discovery, such as virtual ... the team conducted biological experiments, including cell viability assays, immunofluorescence, histological ...
In this webinar brought to you by Lonza, Ethan Shelkey and Aurita Menezes will discuss the effects of donor variability in cell-based assays for measuring drug immunogenicity and immunotoxicity. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results